牛皮治疗管道:概述和更新
Jason E Hawkes1, Miriam Al-Saedy2, Nicole Bouché2
1Department of Dermatology, Integrative Skin Science and Research, Pacific Skin Institute, 1495 River Park Drive, Sacramento, CA 95815, USA.
Dermatologic clinics
|May 25, 2024
概括
最近的进展提供了有效的牛皮治疗方法,新的疗法针对IL-17和IL-23等细胞因子,用于包括牛皮关节炎在内的具有挑战性的病例.
科学领域:
- 皮肤病学和免疫学研究.
- 专注于牛皮病的发病和治疗.
背景情况:
- 在了解牛皮病方面取得了重大进展.
- 开发选择性的局部和全身治疗方法.
- 目前的治疗方法在大多数皮肤牛皮患者中实现了高疾病清除.
研究的目的:
- 解决反抗性牛皮,牛皮关节炎和非斑块变体的未满足需求.
- 突出治疗目标的进展.
- 改善更广泛的牛皮患者群体的临床管理.
主要方法:
- 审查最近的研究和临床开发计划.
- 专注于新的治疗点,包括细胞因子信号通路.
- 评估已批准和正在研究的疗法.
主要成果:
- 现在可以获得高度选择性,有效和安全的治疗方法.
- 许多人取得了前所未有的疾病清除和控制.
- 新兴疗法在难以治疗的疾病方面显示出前景.
结论:
- 针对IL-17A/F,IL-23,TYK2,PDE4,AhR和IL-36信号的新疗法正在扩大治疗选择.
- 改善了患有复发性疾病和牛皮关节炎的患者的管理.
- 提高临床医生照顾各种牛皮表现的能力.
相关概念视频
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Drug Administration and Therapy Phases: Overview
448
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
448
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K


